|
|
 |
Spray invests nationally, across clinical specialties in proprietary technologies where there is a large unmet need. Our target investment profile spans therapeutic technologies as well as diagnostic solutions which enable existing therapies. A portion of our portfolio is dedicated to founding companies with a surgeon/inventor/engineer while the rest is dedicated to more traditional, first institutional round investments. SprayÍs investment appetite ranges according to what makes most sense for the company as they lay out a plan to achieve financeable milestones.
|